Skip to content

Limoneira LMNR Non-cash lease expense

Non-cash lease expense at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$450.75K-5.0%
Medifast logo
MedifastMED
$1.16M+1.3%
BigBear.ai logo
BigBear.aiBBAI
$233K-37.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$439K-22.8%
AngioDynamics logo
AngioDynamicsANGO
$489.5K+1.4%
MGN
MagniteMGNI
$527K+202%

Other financials

Income statement

See full
Revenue$23.9M-31.9%
Gross profit$768.0K-77.5%
Operating income-$21.7M-549%
Net income-$21.4M-537%
EPS (diluted)-$1.20-500%

Balance sheet

See full
Cash & equivalents$891.0K-57.2%
Total debt$99.2M+72.0%
Total equity$152.9M-16.3%
Total assets$293.8M-0.9%

Cash flow

See full
Operating cash flow-$4.5M
CapEx$880.0K+95.1%
Free cash flow-$4.3M

Valuation

See full
Market cap$238.07M-17.7%
Enterprise value$336.42M-2.5%
P/S1.8×+0.2×

Profitability

See full
Gross margin8.5%
Operating margin-33.2%-34.7pp
Net margin-30.5%
FCF margin7.8%

Returns & leverage

See full
Return on equity-24.1%
Debt / equity0.6×+0.3×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Limoneira in its filing.

Tagged under the XBRL concept lmnr:NonCashLeaseExpense.

The official record: Limoneira’s 10-Q, filed June 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Limoneira's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Limoneira's non-cash lease expense?
Limoneira (LMNR) reported non-cash lease expense of $250K in Q1 2026.
How has Limoneira's non-cash lease expense changed year-over-year?
Limoneira's non-cash lease expense decreased by 49.1% year-over-year, from $491K to $250K.
What is the long-term trend for Limoneira's non-cash lease expense?
Over 2 years (2022 to 2025), Limoneira's non-cash lease expense has grown at a 111.3% compound annual growth rate (CAGR), from $442K to $1.97M.
What does non-cash lease expense mean?
This reflects the non-cash portion of lease expenses, typically associated with the amortization of right-of-use assets under lease accounting standards. It is added back to net income in the cash flow statement to reconcile accrual-based accounting with actual cash outflows. Monitoring this helps analysts understand the company's reliance on leased productive assets versus owned assets.